Dr. Chalasani completed medical school in India before he moved to the U.S. to pursue Internal Medicine residency at Emory University in Atlanta, followed by a fellowship in Gastroenterology and Hepatology at the same institution. He joined IU in 1997 as an Assistant Professor in the Division of Gastroenterology and Hepatology. Dr. Chalasani is currently David W. Crabb Professor of Gastroenterology and Hepatology and Adjunct Professor of Anatomy, Cell Biology & Physiology at Indiana University School of Medicine. He previously served as the GI Division Chief (2007-2020), interim Chair of the Department of Medicine (2020-2021) and currently serves as the Vice President for Academic Affairs at Indiana University Health. He is a highly regarded clinician and ranked as Top Doctor continuously for over 15 years. He has been continuously funded by the National Institutes of Health (NIH) since 1999, and is currently the PI on several U01 and R01 awards from the NIH. Dr. Chalasani is considered an authority in the fields of Non-Alcoholic Fatty Liver Disease (NAFLD) and Drug Induced Liver Injury (DILI), two highly significant public health problems. He is one of the most published and most cited investigators at Indiana University, with Google Scholar H-Index 105 and 60,000 citations (as of Feb 2023). He is an elected member of the American Society of Clinical Investigation (ASCI) and the American Association of Physicians (AAP). He has mentored more than 100 trainees and junior faculty members with 19 of his former mentees in faculty positions at major academic centers and 12 are current or former recipients of federal funding. During his tenure as the Division Chief, Dr. Chalasani took the Division of Gastroenterology and Hepatology to new heights, acclaiming national and international reputation, and leading excellence in health care, cutting edge research and teaching.